Skip to main content
ImpediMed's bioimpedance spectroscopy system gains EU approval

European regulators have given ImpediMed CE mark approval for its Sozo bioimpedance spectroscopy platform, which uses the company's L-Dex lateral lymphedema assessment system for noninvasive measurement and monitoring of body composition and fluid status. The platform is designed to be used by patients recovering from a coronary artery disease-related event or those with fluid management problems, heart failure or end-stage renal disease.

Full Story: